LifeMD (LifeMD) Net Issuance of Preferred Stock

: $0.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

LifeMD's net issuance of preferred for the three months ended in Dec. 2023 was $0.0 Mil. The number is 0, which means that LifeMD has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

LifeMD's net issuance of preferred for the trailing twelve months (TTM) ended in Dec. 2023 was $0.0 Mil.

LifeMD Net Issuance of Preferred Stock Historical Data

The historical data trend for LifeMD's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LifeMD Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Issuance of Preferred Stock

2.89

55.34

LifeMD Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Issuance of Preferred Stock																-	-	-	-	-

LifeMD Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

LifeMD Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of LifeMD's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

LifeMD (LifeMD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » LifeMD Inc (NAS:LFMD) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

236 Fifth Avenue, Suite 400, Fourth Floor, New York, NY, USA, 10001

Website

https://www.lifemd.com

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

Executives

Bertrand Velge	director	BARNHOUSE FARM, BARNHOUSE LANE BROOKLAND, ROMNEY MARSH, KENT X0 TN299TR
William J Febbo	director, other: Consultant	600 CALIFORNIA ST., 9TH FLOOR, SAN FRANCISCO CA 94108
Nicholas P Alvarez	officer: Chief Acquisition Officer	C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Eric Harold Yecies	officer: CCO and General Counsel	C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Brad Michael Roberts	officer: Chief Operating Officer	300 CHAFFORD COURT, SIMPSONVILLE SC 29681
Justin Schreiber	director, 10 percent owner, officer: President, Immudyne PR	236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Stefan Galluppi	director, officer: Chief Operating Officer	C/O LIFEMD, INC, 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Joan Larovere	director	C/O LIFEMD, 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Jessica Friedeman	officer: Chief Marketing Officer	C/O LIFEMD, 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Kathleen E Walsh	director	C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Piyush Jindal	director	C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Joseph Ditrolio	director	C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Maria E. Stan	officer: Principal Accounting Officer	236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Dennis Wijnker	officer: Chief Technology Officer	536 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Naveen Bhatia	director	823 GREENTREE RD, PACIFIC PALISADES CA 90272